Suchergebnisse - "Grammer, Tanja B"

PubPharm (207)

1

The German CaRe high registry for familial hypercholesterolemia - Sex differences, treatment strategies, and target value attainment

enthalten in: Atherosclerosis plus | 2023

von März, W. | Schmidt, N. | An Haack, I. | +27

2

J-shaped association between circulating apoC-III and cardiovascular mortality

enthalten in: European journal of preventive cardiology | 2022

von Silbernagel, G. | Scharnagl, H. | Kleber, M. | +12

3

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease : A retrospective study

enthalten in: PLoS medicine | 2021

von Wallentin, L. | Eriksson, N. | Olszowka, M. | +10

4

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease : a retrospective study

enthalten in: PLoS medicine | January 13, 2021

von Wallentin, L. | Eriksson, N. | Olszowka, M. | +10

5

Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease

enthalten in: Atherosclerosis | 2020

von Silbernagel, G. | Scharnagl, H. | Kleber, M. | +12

6

Author Correction : Cardiovascular risk algorithms in primary care: Results from the DETECT study

enthalten in: Scientific reports | 2020

von Grammer, T. | Dressel, A. | Gergei, I. | +10

ErratumFor: Sci Rep. 2019 Jan 31;9(1):1101. - PMID 30705337

7

Area-based socioeconomic status and mortality : the Ludwigshafen Risk and Cardiovascular Health study

enthalten in: Clinical research in cardiology : official journal of the German Cardiac Society | 2020

von Moissl, A. | Delgado, G. | Krämer, B. | +3

8

Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays

enthalten in: Atherosclerosis | 2019

von Scharnagl, H. | Stojakovic, T. | Dieplinger, B. | +6

CommentIn: Atherosclerosis. 2019 Oct;289:181-183. - PMID 31495537

9

Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease : Insights from the Ludwigshafen Risk and Cardiovascular Health cohort

enthalten in: Vascular pharmacology | 2019

von Dressel, A. | Schmidt, B. | Schmidt, N. | +5

10

Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study)

enthalten in: Clinical chemistry | 2019

von Grammer, T. | Scharnagl, H. | Dressel, A. | +8

CommentIn: Clin Chem. 2019 Jul;65(7):821-823. - PMID 31040098

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]